Comparison of oral anticoagulation and antiplatelet therapy during the midperiod after percutaneous left atrial appendage closure
During the midperiod time after LAAC implantation with the WATCHMAN device, OAC therapy may demonstrate similar safety and efficacy compared with dual antiplatelet therapy.
Authors
- Lu Zhou (ORCID: https://orcid.org/0000-0002-7274-8910)
- Deyong Long
- Caihua Sang
- Lihong Huang (ORCID: https://orcid.org/0000-0002-7261-316X)
- Jingrui Zhang (ORCID: https://orcid.org/0000-0001-7732-8459)
- Songnan Li (ORCID: https://orcid.org/0000-0002-3139-663X)
- Changyi Li (ORCID: https://orcid.org/0000-0003-3667-3007)
- Jianzeng Dong (ORCID: https://orcid.org/0000-0002-3847-6069)
- Lizhu Guo
Institutions
- Capital Medical University (CN)
- Beijing Anzhen Hospital (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-11-27
- DOI
- https://doi.org/10.3389/fcvm.2025.1637290
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00